For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts

Blog
FDA can’t stomach fluoride and doesn’t want you to, either
On May 13, the Food and Drug Administration (FDA) announced that it would begin a process intended to exclude ingestible prescription fluoride products for…

Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…

Blog
The MAHA Report is a missed opportunity
Less than six months into the new administration, the Department of Health and Human Services (HHS) has produced its Make Our Children Healthy Again…
Search Posts
Op-Eds
Deadly Overcaution: FDA’s Drug Approval Process
Full article available in PDF When the federal Food and Drug Administration announces its approval of an important new drug, the…
Op-Eds
The Liberating Benefits Of Automobility
Full Article Available in PDF Format American’s love affair with the automobile has become…
Op-Eds
Biotechnology Flirts with the Regulators
Biotechnology, like other unfamiliar high tech industries, offers great hopes but arouses even greater fears. Politicians, the record proves, are far more likely to respond to…
News Release
AIDS Protest at FDA: The Issue Is Freedom
The Competitive Enterprise Institute, a Washington-based free market advocacy group, today expressed its support for the AIDS protest at the Food & Drug Administration…
Citation
CAFE’s Casualties
Citation